Article Information
History
- January 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Katrina Spensley1,2,
- Sarah Gleeson2,
- Paul Martin2,
- Tina Thomson2,
- Candice L. Clarke1,2,
- Graham Pickard3,
- David Thomas1,2,
- Stephen P. McAdoo1,2,
- Paul Randell3,
- Peter Kelleher3,4,
- Rachna Bedi2,
- Liz Lightstone1,2,
- Maria Prendecki1,2 and
- Michelle Willicombe1,2,*
- 1Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN
- 2Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, W12 0HS
- 3Department of Infection and Immunity Sciences Northwest London Pathology NHS Trust, Charing Cross Hospital, Fulham Palace Road W6 6RF
- 4Department of Infectious Diseases, Imperial College London, Chelsea &Westminster Hospital Campus, Fulham Road London SW10 9NH
- ↵*Corresponding author: Dr Michelle Willicombe, Centre for Inflammatory Disease Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, E-mail: m.willicombe08{at}imperial.ac.uk
Posted January 26, 2022.
Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis
